-
RegMed XB is a translational product development platform that brings together Dutch and Flemish public and private stakeholders to accelerate the development of innovative regenerative therapies.
Infrastructure: RegMed XB's Pilot Factory
A seamless pathway for innovators to accelerate, de-risk, and scale regenerative therapies
read more
-
One step closer to therapies based on cartilage regeneration
Congratulations to Margot Rikkers on the publication of the paper “Importance of Timing of Platelet Lysate-Supplementation in Expanding or Redifferentiating Human Chondrocytes for Chondrogenesis” in the Preclinical Cell and Gene therapy section of Frontiers in Bioengineering and Biotechnology magazine.
read more
Renal replacement therapy in Regenerative Medicine
Thomas Geuens, Vanessa LaPointe and Clemens van Blitterswijk from MERLN Institute of Maastricht University have published the paper “Overcoming kidney organoid challenges for regenerative medicine” discussing the recent advances and remaining challenges for kidney organoids to become successful in regenerative medicine.
read more
An ex vivo human osteochondral culture model
Congratulations to Meike W.A. Kleuskens on the publication of her paper “An ex vivo human osteochondral culture model” in the Journal of Orthopaedic Research.
read more -
Moonshots (research excellence)
-
Pilot Factory (infrastructure)
The RegMed XB Pilot Factory is one of the largest international infrastructures for regenerative medicine. It brings together all the expertise and infrastructure needed to bring regenerative medicine to the market.
-
RegMed XB's Ecosystem
Health Foundations
The following Dutch health foundations are involved in defining research objectives and provide guidance in the research we conduct to ensure we maintain focus on the patient.
read moreAcademic Partners
RegMed XB works together with (inter)national top-rated academic institutions and collaborates specifically and exclusively with researchers who contribute specific expertise to the Moonshot initiatives.
read moreIndustrial Partners
Partnering with companies offers access to their expertise in designing scalable and feasible products. Currently, we have strong partnerships with the following entities.
read moreGovernmental Partners
RegMed XB receives support from national and local governments to de-risk promising concepts from academia to proof of concept or initial clinical trial stages.
read more -
-
-
-
-
-
-
